A detailed history of Mendota Financial Group, LLC transactions in Organon & Co. stock. As of the latest transaction made, Mendota Financial Group, LLC holds 29 shares of OGN stock, worth $519. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Previous 9 222.22%
Holding current value
$519
Previous $189,000 194.71%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$18.65 - $23.03 $373 - $460
20 Added 222.22%
29 $557,000
Q2 2024

Jul 11, 2024

SELL
$17.45 - $21.96 $87 - $109
-5 Reduced 35.71%
9 $189,000
Q2 2023

Jul 27, 2023

BUY
$19.27 - $24.63 $19 - $24
1 Added 7.69%
14 $285,000
Q4 2022

Feb 03, 2023

BUY
$23.31 - $28.61 $303 - $371
13 New
13 $375,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.56B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.